1. Background {#sec0005}
=============

Accurate identification of respiratory pathogens is important in clinical medicine and research. In bacteriology, upper airway sampling can misrepresent the lower airway microbiota [@bib0005], [@bib0010]. In contrast, there is little such comparative data for virology. Nasopharyngeal aspirates (NPA) or nasal washes are regarded as the specimen of choice for detection of upper respiratory tract viruses by polymerase chain reaction (PCR) [@bib0015], [@bib0020]. Upper airway sampling is relatively simple, can be performed at the bedside and is minimally invasive. In contrast, lower airway sampling in young children is invasive, requiring a bronchoalveolar lavage (BAL).

Traditionally, BAL has been considered the 'gold-standard' for the microbiological diagnosis (viral and bacterial) of lower respiratory tract infection in children. However, as BAL requires specialist input and is often performed under anesthesia, it is reserved for patients with complex or severe disease, e.g., in the setting of intensive care; immune-compromise or in children with chronic or recurrent respiratory tract symptoms. The disparities in ease of collection of NPA versus BAL, raise two important questions. Firstly, what is the comparative yield of NPA compared to BAL for respiratory virus detection in children? Secondly, what is the significance of a positive NPA with respect to lower airway inflammation? Given the lack of studies addressing these important questions [@bib0025], [@bib0030], we evaluated paired NPA and BAL specimens in 75 children.

2. Objectives {#sec0010}
=============

To compare the yield and diagnostic parameters of respiratory virus detection on NPA versus BAL using molecular methods, and to evaluate whether virus positivity on NPA correlates with lower airway neutrophilic inflammation and by inference, active viral pulmonary disease.

3. Study design {#sec0015}
===============

The Queensland Children\'s Health Services Ethics Committee approved the study and written informed consent was obtained from each parent or guardian. Children undergoing flexible bronchoscopy, for any clinical indication, as arranged by their treating physician, were eligible. Samples evaluated in this article were obtained from children recruited to a larger cohort study on chronic cough in children [@bib0035]. Caregivers completed a standardized clinical questionnaire on the day of bronchoscopy including current respiratory symptoms and relevant demographics. Children with symptoms of significant acute lower respiratory tract infection, e.g., high fever, tachypnea/shortness of breath, wheeze or rattly chest were deemed, by an anesthetist, to be unfit for anesthesia and excluded from the study.

Contemporaneous NPA and BAL sampling was performed under general anesthesia. NPA was collected first, using a disposable catheter connected to a mucous trap. Dry nasopharyngeal suction, via both nares, was performed, followed by suction of 2--3 ml of sterile normal saline directly into the suction catheter to rinse through remaining contents.

Bronchoscopic BAL was then performed using standardized methods as per European Respiratory Society guidelines [@bib0040]. Sterile normal saline, in three aliquots of 1 ml/kg (maximum 20 ml), was instilled into the most affected area, or right middle lobe in patients with generalized disease. To minimize upper airway contamination, suction through the bronchoscope was avoided until the tip had entered the distal airways. The first aliquot was used for microbiological testing, the second and third were pooled for cellularity studies.

Viral studies were undertaken using real-time PCR techniques, as described previously [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], to detect 16 respiratory virus types and subtypes. These included human rhinoviruses (HRV), human adenoviruses (HAdV), respiratory syncytial virus (RSV), human influenza A virus (IFAV), human influenza B virus (IFBV), human para-influenza virus 1--3 (HPIV1--3), human metapneumovirus (hMPV), human bocavirus (HBoV), human coronaviruses (HCoV -- NL63, OC43, 229E, HKU1), WU polyomavirus (WUPyV) and KI polyomavirus (KIPyV). BAL specimens were refrigerated immediately and processed within 24 h. NPA specimens were stored at −70 °C prior to processing.

We defined positive bacterial culture as growth of ≥10^5^  colony-forming units (cfu)/ml [@bib0050] of any of the following pathogens on BAL: *Streptococcus pneumoniae*, *Moraxella catarrhalis*, *Haemophilus influenzae*, *Pseudomonas aeruginosa*, *Staphylococcus aureus* or Enterobacteriaceae. Total cell count and differential profile (minimum 400 cells counted) were performed on BAL as described previously [@bib0070].

3.1. Statistical analyses {#sec0020}
-------------------------

Statistical analyses were carried out using IBM SPSS (v20, San Francisco, USA). Medians and inter-quartile ranges were reported as data were non-normally distributed. Kappa analyses were used to assess levels of agreement between sampling techniques. Comparisons of categorical variables were performed using Pearson\'s *χ* ^2^ test or Fisher exact test if any category had an expected value of \<5. Mann--Whitney *U* test was used for two group comparisons and Kruskal--Wallis test for \>2 groups comparisons of continuous variables. Multiple linear regression was employed to adjust for virus co-detection and bacterial infection. A two-tailed *p*-value \<0.05 was considered statistically significant. Sensitivity, specificity, positive and negative predictive values and likelihood ratios were manually calculated.

4. Results {#sec0025}
==========

Between February 2010 and May 2012, paired NPA and BAL samples were obtained from 75 children (median age = 33 months, IQR 16, 69; male *n*  = 50, 66.7%). One-third of children (*n*  = 25, 33.3%) were exposed to household cigarette smoke. Chronic cough (≥4 weeks) was reported in 45 participants (60%) at time of bronchoscopy. The major diagnoses within the cohort included: protracted bacterial bronchitis (*n*  = 31, 41%) and bronchiectasis (*n*  = 17, 23%); the remaining participants had either no specific diagnosis (*n*  = 22, 29%) or a congenital airway abnormality (*n*  = 5, 7%). The most common viruses detected on NPA were HRV (*n*  = 44) and HAdV (*n*  = 15). In regard to seasonality, HAdV positivity on BAL was more likely to occur in spring or summer than winter or autumn (*p*  = 0.004) using chi-square analysis. HRV detections followed a bimodal distribution with peak detections occurring in spring and autumn.

4.1. Comparison of yield on paired NPA and BAL samples {#sec0030}
------------------------------------------------------

Of the 75 paired NPA and BAL samples, 52 (69.3%) children had one or more virus detected from NPA and 38 (50.7%) had one or more virus from BAL. When considering detection of any virus, 32 (42.7%) NPA-BAL pairs were concordant PCR-positive, 17 (22.7%) pairs were concordant PCR-negative and 26 (34.7%) pairs had discordant PCR results. Of the discordant pairs, most (*n*  = 20, 76.9%) were PCR positive on NPA but negative on BAL. Detection rates varied among the different viruses ([Table 1](#tbl0005){ref-type="table"} ). Most marked was the difference between NPA and BAL for HRV. Using positive PCR on BAL as an arbitrary gold standard, we calculated sensitivity, specificity, positive and negative predictive values and likelihood ratios ([Table 1](#tbl0005){ref-type="table"}). HRV and HAdV were the most common viruses detected from NPA and BAL. Levels of agreement between NPA and BAL varied among the different viruses. The agreement between NPA and BAL for HRV was poor, kappa = 0.398 (95%CI 0.218, 0.578, *p*  \< 0.001) but good for HAdV at 0.561 (95%CI 0.321, 0.801, *p*  \< 0.001).Table 1Absolute number of virus detections by PCR from paired NPA/BAL samples (*n* = 75) with diagnostic test parameters (BAL as the arbitrary gold-standard).NPA/BALHRVHAdVOther[a](#tblfn0005){ref-type="table-fn"}HBoVHCoVWUPyV/KIPyVTotal[b](#tblfn0010){ref-type="table-fn"}NPA+4415574[c](#tblfn0015){ref-type="table-fn"}452BAL+2413443[c](#tblfn0015){ref-type="table-fn"}138NPA+/BAL−2261[d](#tblfn0020){ref-type="table-fn"}53420NPA−/BAL+2402216NPA+/BAL+229421032NPA−/BAL−29567066697017Sensitivity92%69%--50%33%--84%Specificity57%90%99%93%96%--46%PPV0.50.60.800.290.25--0.62NPV0.940.93--0.970.97--0.74LR+2.127.15--7.107.99--1.56LR−0.190.34--0.540.70--0.35Kappa0.400.560.880.320.250.020.30[^1][^2][^3][^4][^5]

4.2. Relationship between virus positivity and BAL neutrophilia {#sec0035}
---------------------------------------------------------------

The median lower airway %neutrophils were significantly higher in children who were NPA-positive for any virus compared to NPA-negative children (19 \[IQR 7, 65\] vs. 11 \[IQR 3, 21.5\]; *p*  = 0.045). Total cell counts (TCCs), %macrophages, %lymphocytes and %eosinophils were similar across groups (data not shown). When evaluating the two most frequent viruses, HRV and HAdV ([Table 2](#tbl0010){ref-type="table"} ), presence of HAdV in the NPA was significantly associated with increased BAL neutrophilia (*p*  = 0.017) whereas HRV status on NPA showed no association with %neutrophils (*p*  = 0.514).Table 2Lower airway cellular differential versus virus status on NPA and BAL.Lower airway cellular profileNPA HRV+ (*n* = 44)NPA HRV− (*n* = 31)*p*-ValueNPA AdV+ (*n* = 15)NPA AdV− (*n* = 60)*p*-ValueTCCs (×10^6^/L)215 (106, 285)240 (94, 360)0.894260 (168, 473)200 (90, 290)0.132Neutr%16 (6, 55)13 (4, 32)0.51451 (15, 68)12 (5, 36)0.017Macr%60 (37, 82)71 (29, 87)0.60546 (23, 74)71 (41, 84)0.075Lymph%6 (4, 13)6 (3, 15)0.8125 (2, 11)6 (4, 15)0.183Eosin%0 (0, 0)0 (0, 0)0.2620 (0,2)0 (0,0)0.314Lower airway cellular profileBAL HRV+ (*n* = 24)BAL HRV− (*n* = 51)*p*-ValueBAL AdV+ (*n* = 13)BAL AdV− (*n* = 62)*p*-ValueTCCs (×10^6^/L)210 (108, 413)230 (95, 350)0.645240 (112, 485)215 (94, 285)0.534Neutr%16 (9, 63)15 (5, 40)0.45744 (14, 70)12 (5, 37)0.077Macr%65 (27, 82)68 (39, 84)0.54454 (25, 83)70 (38, 84)0.497Lymph%8 (5, 20)5 (3, 14)0.3183 (2, 7)7 (5, 15)0.017Eosin%0 (0, 2)0 (0, 0)0.1620 (0, 1)0 (0, 0)0.825[^6]

Similar to the NPA findings, the presence of any virus in the BAL was associated with higher median %neutrophils compared to the virus-negative state (23 \[IQR 10, 67\] vs. 11 [@bib0025], [@bib0140], respectively; *p*  = 0.04). Median lower airway TCC was higher in BAL virus-positive (235 × 10^6^/L \[IQR 115, 448\]) versus virus-negative (160 × 10^6^/L \[58, 255\]) groups (*p*  = 0.068). No differences in lymphocyte counts was observed when considering total viruses, but for individual viruses, %lymphocytes were significantly lower in HAdV BAL positive compared to HAdV BAL negative participants (*p*  = 0.017). Children who were HAdV positive on BAL had higher %neutrophils than those who were HAdV negative on BAL (*p*  = 0.077). In comparison, %neutrophils were similar across HRV positive and negative groups on BAL (*p*  = 0.457).

4.3. Regression analysis adjusting for virus co-detection and bacterial infection {#sec0040}
---------------------------------------------------------------------------------

On multi-variable analysis, HRV in either NPA or BAL showed no association with lower airway %neutrophils. In contrast, HAdV in NPA and/or BAL was significantly associated with increased %neutrophils on BAL ([Table 3](#tbl0015){ref-type="table"} ). Bacterial infection was detected in over half (32; 61.5%) of NPA virus positive participants with much lower rates (6; 26.1%) in virus negative participants (*p*  = 0.005). Rates of bacterial infection in BAL virus positive (22; 57.9%) children were also greater than BAL virus negative children (16; 43.2%); however, this difference was not significant (*p*  = 0.204). The predominant bacterial organisms were: *H. influenzae*, *M. catarrhalis* and *S. pneumoniae*. Presence of bacterial infection as seen on BAL had the strongest independent influence on lower airway neutrophil counts (beta = 0.256 and 0.311 for NPA and BAL, respectively) as shown in [Table 3](#tbl0015){ref-type="table"}.Table 3Multiple linear regression of mean difference in lower airway %neutrophils according to infective status on NPA and BAL.Unadjusted[a](#tblfn0025){ref-type="table-fn"} mean difference in neutr% (IQR)*p*-ValueAdjusted[b](#tblfn0030){ref-type="table-fn"} mean difference in neutr% (IQR)*p*-Value[c](#tblfn0035){ref-type="table-fn"}Beta[d](#tblfn0040){ref-type="table-fn"}**NPA**HAdV20 (3, 37)0.02018 (1, 35)0.0420.245HRV5 (−9, 19)0.486−2 (−16, 12)0.782−0.033Bacteria ≥ 10^5^ cfu/ml (on BAL)16 (3, 30)0.01615 (1, 28)0.0350.256  **BAL**HAdV15 (−3, 32)0.09718 (0.3, 35)0.0460.235HRV4 (−10, 19)0.5500 (−14, 15)0.9500.007Bacteria ≥ 10^5^ cfu/ml (on BAL)16 (3, 30)0.01618 (4, 31)0.010.311[^7][^8][^9][^10]

5. Discussion {#sec0045}
=============

In this study, we systematically compared upper airway (NPA) to lower airways (BAL) sampling with regards to diagnostic yield for respiratory viruses in children with non-acute respiratory illness. We found that concordance of NPA with BAL is largely dependent on the virus being investigated. NPA has good concordance with BAL for detection of HAdV, but poor concordance for HRV. In comparison to BAL, sensitivity, specificity, PPV and NPV of the most frequently detected viruses on NPA differed according to the virus being investigated. Specificity was high for all viruses, except for HRV. The reverse was observed with regards to sensitivity. Lastly, presence of HAdV on NPA and/or BAL was associated with significantly heightened %neutrophils in the lower airway.

To our knowledge, three major studies have compared upper and lower airway specimens for respiratory virus detection. All were limited by unpaired specimens or focused on specific diseases or viruses. The first compared NPA to BAL in lung transplant recipients using unpaired, non-contemporaneous NPA and BAL specimens obtained from 72 and 56 participants for NPA and BAL, respectively. A higher yield of hMPV was seen in NPA compared to BAL, with comparable rates of IFAV, HPIV, RSV, HCoV and HRV [@bib0030]. Diagnostic accuracy of NPA for BAL was not assessed in this study [@bib0030]. The second study used paired specimens, obtained from 21 participants on 92 occasions, and compared induced sputum to NPA for detection of respiratory viruses in children with cystic fibrosis. HRV was the most common virus identified and was present in the same frequency (21.7%) in NPA and sputum. Concordance rates were higher than in the present study (87% for HRV and 92% for other viruses), with higher sensitivity and specificity (70% and 91.7%, respectively) [@bib0075]. The third study compared paired nasal wash/tracheal suction specimens to BAL in terms of RSV detection in 6 participants, and found BAL was superior for detection of RSV using antigen detection and culture methods (insensitive methods when compared to PCR) [@bib0025].

Studies directly comparing NPA to BAL have focused on atypical pneumonia. The first study evaluated *Pneumocystis jiroveci* pneumonia and the second compared detection methods for mycoplasma pneumonia. Both studies found high concordance between NPA and BAL. However, in contrast to our findings, in both studies, BAL had a higher yield of positive detections than NPA. Interestingly, in the study on mycoplasma pneumonia, BAL positivity was associated with increased lower airway %neutrophils, however, NPA positivity was not. These differing findings may reflect the different modes of transmission and mechanisms of disease progression between viral and bacterial infections of the respiratory tract.

Our study showed that NPA/BAL discordance was most marked for HRV, where 22 (29.3%) children were NPA-positive but BAL-negative. In contrast, HAdV was more likely to also be found in the lower airway, with only 2 NPA-positive/BAL-negative children. Previous studies have found HRV to have greater propensity to infect the nasopharynx and proximal lower airways than the distal airways or alveoli [@bib0080]. This may be related to HRV\'s ability to replicate optimally at cooler temperatures of the upper airway [@bib0085], although this finding is inconsistent across HRV types [@bib0090]. In vivo studies demonstrate that HRV induces minimal epithelial cytotoxicity with only a small subset of nasal and bronchial mucosal cells becoming infected [@bib0080], [@bib0095], [@bib0100]. These factors may explain why HRV is an uncommon cause of pneumonia, except in the immune-compromised host [@bib0105]. Whilst HRV and HAdV can both cause uncomplicated upper respiratory tract infection [@bib0110], disease manifestation differs at the severe end of the spectrum. HRV has been shown to play an important role in asthma exacerbations [@bib0115]; HAdV has been implicated in the pathogenesis of obliterative bronchiolitis and bronchiectasis [@bib0120]. Thus, differences between HAdV and HRV in their mechanisms of propagation and respiratory disease pathogenesis are likely to explain our observations.

Our cross-sectional findings of elevated rates of HRV (59%) in children who were essentially free of acute RVI symptoms is higher than prior studies showing asymptomatic HRV nasopharyngeal detection ranging from 12% to 33% [@bib0125], [@bib0130], [@bib0135]. HRV is frequently identified in patients with viral:bacterial co-infection [@bib0140], a fact that may have relevance to our cohort of children with high rates of bacterial infection and chronic cough.

To further understand the implications of our findings in relation to lower airway neutrophilic inflammation and virus detection, the distinction between positive virus detection and active viral disease merits discussion. A PCR-positive NPA in a child without overt symptoms of acute RVI is often believed to represent viral genome shedding from a resolving infection [@bib0145] or preceding a new symptomatic episode. However, certain HAdV types can cause prolonged host shedding [@bib0150] with intermittent viral excretion over months to years [@bib0155], [@bib0160]. In contrast, HRVs usually do not persist. Garnett et al. postulate that "smoldering HAdV at the site of lung inflammation" may contribute to the pathogenesis of lung diseases such as chronic obstructive pulmonary disease (COPD) in adults [@bib0165]. Our finding of low BAL %lymphocytes, together with neutrophilia, in children who were HAdV DNA positive on BAL, supports the notion that active lower airway HAdV replication was likely to be occurring (as opposed to latent HAdV infection of lymphocytes). Whether such persistence of HAdV viral DNA within the respiratory tract of children is benign or contributes to the development of chronic lung disease/s is unknown.

The major strengths of this study are its prospective design, the use of highly sensitive PCR techniques to detect a wide range of respiratory viruses, contemporaneous detection of lower airway bacteria and inclusion of BAL cellularity findings. However, there are a number of limitations. Firstly, this study involved children with chronic respiratory symptoms, predominantly cough. Hence, these findings may not be readily extrapolated to healthy children or to those with acute lower respiratory tract illness. This is particularly pertinent to influenza and RSV, as there were very few children in whom these viruses were detected. Secondly, we used neutrophilic lower airway inflammation as a surrogate marker for active pulmonary disease, as used by other authors [@bib0170], [@bib0175]. We did not, however, test for additional indirect markers of viral infection such as Toll-like receptor 3 (TLR3), interferon gamma induced protein 10 (IP-10) or virus-specific antibodies. Thirdly, we only obtained BAL samples at a single time-point, precluding the ability to make inferences regarding causality. Lastly, although we were fastidious in our BAL technique, contamination of the bronchoscope in its route through the upper airway is possible. The significant number of BAL positive/NPA negative cases, however, negates the argument that contamination could account for all lower airway detections.

In conclusion, we have shown that while upper airway sampling is the most practical and frequently used method of assessing virus presence, it does not necessarily reflect virus in the lower airways in children with non-acute respiratory illness. However, certain viruses (e.g., HAdV), when detected on NPA, may provide clues to the existence of lower airway neutrophilic inflammation and further research is needed. Studies addressing acute viral respiratory tract illnesses in children are required to ascertain the applicability of our findings to the acute setting.
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[^1]: *Abbreviations*: PPV, positive predictive value; NPV, negative predictive value; LR+, positive likelihood ratio; LR−, negative likelihood ratio.

[^2]: RSV, IFA/B, HPIV1-3, hMPV.

[^3]: Total no. of children with one or more viruses detected.

[^4]: HCoV-OC43.

[^5]: HPIV-1.

[^6]: *Abbreviations*: Neutr%, percentage neutrophils; Macro%, percentage macrophages; Lymph%, percentage lymphocytes; Eosin%, percentage eosinophils. Cell counts expressed as median (interquartile range) and rounded to nearest whole number.

[^7]: Unadjusted mean difference in %neutrophils between HAdV, HRV and bacteria positive and negative groups calculated using independent samples *t*-test.

[^8]: Adjusted mean difference in %neutrophils using multiple linear regression (adjusted for viral co-detection and bacterial infection).

[^9]: *p*-Values remain significant after logarithmic transformation of %neutrophils therefore mean differences reported.

[^10]: Standardized coefficient indicates independent influence of variable on %neutrophils.
